GC Biopharma Corp. (KRX: 006280)
South Korea
· Delayed Price · Currency is KRW 166,700
-2,300 (-1.36%)
Dec 20, 2024, 3:30 PM KST
36.98% (1Y)
| Market Cap | 1.90T |
| Revenue (ttm) | 1.64T |
| Net Income (ttm) | -18.85B |
| Shares Out | 11.41M |
| EPS (ttm) | -1,652.01 |
| PE Ratio | n/a |
| Forward PE | 81.71 |
| Dividend | 1,500.00 (0.90%) |
| Ex-Dividend Date | Dec 27, 2024 |
| Volume | 41,280 |
| Open | 167,200 |
| Previous Close | 169,000 |
| Day's Range | 163,500 - 170,500 |
| 52-Week Range | 107,600 - 181,800 |
| Beta | 1.03 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 14, 2025 |